Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meixia Chen

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science China. Life Sciences|March 25, 2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsYajing Zhang, Wenying Zhang, Hanren Dai, et al.
Cell Reports|March 28, 2025
Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the bodyQian Du, Wei He, Xiangjie Chen, et al.
Frontiers in Cellular and Infection Microbiology|July 31, 2018
Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic <i>Escherichia Coli</i>-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 CellsHaitao Yu, Xiuliang Ding, Lijun Shang, et al.
Oncoimmunology|June 15, 2018
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialYao Wang, Meixia Chen, Zhiqiang Wu, et al.
Nature Communications|December 5, 2025
Interface-controlled antiferromagnetic tunnel junctions based on a metallic van der Waals A-type antiferromagnetWei-Min Zhao, Yi-Lun Liu, Liu Yang, et al.
Journal of Immunology Research|June 26, 2014
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II reportHui Fan, Xuechun Lu, Xiaohui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2019
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin LymphomaJing Nie, Chunmeng Wang, Yang Liu, et al.
Cell Research|August 26, 2020
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapyMengze Lv, Meixia Chen, Rui Zhang, et al.
Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 26, 2017
The Anti-Inflammatory Effects of Invigorating Kidney and Supplementing Qi Chinese Herbal Formulae in Asthma PatientsLingwen Kong, Hongying Zhang, Yuxue Cao, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science China. Life Sciences|March 25, 2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsYajing Zhang, Wenying Zhang, Hanren Dai, et al.
Cell Reports|March 28, 2025
Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the bodyQian Du, Wei He, Xiangjie Chen, et al.
Frontiers in Cellular and Infection Microbiology|July 31, 2018
Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic <i>Escherichia Coli</i>-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 CellsHaitao Yu, Xiuliang Ding, Lijun Shang, et al.
Oncoimmunology|June 15, 2018
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialYao Wang, Meixia Chen, Zhiqiang Wu, et al.
Nature Communications|December 5, 2025
Interface-controlled antiferromagnetic tunnel junctions based on a metallic van der Waals A-type antiferromagnetWei-Min Zhao, Yi-Lun Liu, Liu Yang, et al.
Journal of Immunology Research|June 26, 2014
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II reportHui Fan, Xuechun Lu, Xiaohui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2019
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin LymphomaJing Nie, Chunmeng Wang, Yang Liu, et al.
Cell Research|August 26, 2020
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapyMengze Lv, Meixia Chen, Rui Zhang, et al.
Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 26, 2017
The Anti-Inflammatory Effects of Invigorating Kidney and Supplementing Qi Chinese Herbal Formulae in Asthma PatientsLingwen Kong, Hongying Zhang, Yuxue Cao, et al.
Pageof 12